Cathay Biotech Inc.
688065.SS · SHH
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | CN¥3 | CN¥2 | CN¥2 | CN¥2 |
| % Growth | 39.9% | -13.4% | 3.3% | – |
| Cost of Goods Sold | CN¥2 | CN¥2 | CN¥2 | CN¥2 |
| Gross Profit | CN¥1 | CN¥1 | CN¥1 | CN¥1 |
| % Margin | 28.3% | 27.4% | 34% | 35.4% |
| R&D Expenses | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| G&A Expenses | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| SG&A Expenses | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Sales & Mktg Exp. | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Other Operating Expenses | -CN¥0 | -CN¥0 | -CN¥0 | -CN¥0 |
| Operating Expenses | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Operating Income | CN¥1 | CN¥0 | CN¥1 | CN¥1 |
| % Margin | 18.6% | 21.5% | 29% | 30.6% |
| Other Income/Exp. Net | -CN¥0 | -CN¥0 | -CN¥0 | CN¥0 |
| Pre-Tax Income | CN¥1 | CN¥0 | CN¥1 | CN¥1 |
| Tax Expense | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Net Income | CN¥0 | CN¥0 | CN¥1 | CN¥1 |
| % Margin | 16.5% | 17.3% | 22.7% | 25.2% |
| EPS | 0.84 | 0.63 | 0.95 | 1.43 |
| % Growth | 33.3% | -33.7% | -33.6% | – |
| EPS Diluted | 0.84 | 0.63 | 0.95 | 1.43 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 0 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Interest Expense | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Depreciation & Amortization | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| EBITDA | CN¥1 | CN¥0 | CN¥1 | CN¥1 |
| % Margin | 23% | 21.3% | 27.5% | 28.3% |